193 related articles for article (PubMed ID: 26488313)
1. Refined models of New Delhi metallo-beta-lactamase-1 with inhibitors: an QM/MM modeling study.
Wang YT; Cheng TL
J Biomol Struct Dyn; 2016 Oct; 34(10):2214-23. PubMed ID: 26488313
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor and substrate binding by New Delhi metallo-beta-lactamase-1: a molecular dynamics studies.
Wang YT; Lu CY; Hour TC; Cheng TL
Curr Comput Aided Drug Des; 2014; 10(3):197-204. PubMed ID: 25479381
[TBL] [Abstract][Full Text] [Related]
3. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
Muteeb G; Alsultan A; Farhan M; Aatif M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.
Salari-Jazi A; Mahnam K; Sadeghi P; Damavandi MS; Faghri J
Sci Rep; 2021 Jan; 11(1):2390. PubMed ID: 33504907
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulation studies of novel β-lactamase inhibitor.
Ul Haq F; Abro A; Raza S; Liedl KR; Azam SS
J Mol Graph Model; 2017 Jun; 74():143-152. PubMed ID: 28432959
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
[TBL] [Abstract][Full Text] [Related]
7. A modified bonded model approach for molecular dynamics simulations of New Delhi Metallo-β-lactamase.
Eshtiwi AA; Rathbone DL
J Mol Graph Model; 2023 Jun; 121():108431. PubMed ID: 36827734
[TBL] [Abstract][Full Text] [Related]
8. Hydrolysis of cephalexin and meropenem by New Delhi metallo-β-lactamase: the substrate protonation mechanism is drug dependent.
Das CK; Nair NN
Phys Chem Chem Phys; 2017 May; 19(20):13111-13121. PubMed ID: 28489087
[TBL] [Abstract][Full Text] [Related]
9. Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1.
Mulligan VK; Workman S; Sun T; Rettie S; Li X; Worrall LJ; Craven TW; King DT; Hosseinzadeh P; Watkins AM; Renfrew PD; Guffy S; Labonte JW; Moretti R; Bonneau R; Strynadka NCJ; Baker D
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723038
[TBL] [Abstract][Full Text] [Related]
10. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
Linciano P; Cendron L; Gianquinto E; Spyrakis F; Tondi D
ACS Infect Dis; 2019 Jan; 5(1):9-34. PubMed ID: 30421910
[TBL] [Abstract][Full Text] [Related]
11. New Delhi metallo-β-lactamase I: substrate binding and catalytic mechanism.
Zheng M; Xu D
J Phys Chem B; 2013 Oct; 117(39):11596-607. PubMed ID: 24025144
[TBL] [Abstract][Full Text] [Related]
12. The role of conserved residues in the catalytic activity of NDM-1: an approach involving site directed mutagenesis and molecular dynamics.
Ali A; Kumar R; Iquebal MA; Jaiswal S; Kumar D; Khan AU
Phys Chem Chem Phys; 2019 Aug; 21(32):17821-17835. PubMed ID: 31373340
[TBL] [Abstract][Full Text] [Related]
13. The Effects of One-Point Mutation on the New Delhi Metallo Beta-Lactamase-1 Resistance toward Carbapenem Antibiotics and β-Lactamase Inhibitors: An In Silico Systematic Approach.
Tran VT; Tran VH; Nguyen DN; Do TG; Vo TP; Nguyen TT; Huynh PNH; Thai KM
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555726
[TBL] [Abstract][Full Text] [Related]
14. Structure-based computational study of the hydrolysis of New Delhi metallo-β-lactmase-1.
Zhu K; Lu J; Ye F; Jin L; Kong X; Liang Z; Chen Y; Yu K; Jiang H; Li JQ; Luo C
Biochem Biophys Res Commun; 2013 Feb; 431(1):2-7. PubMed ID: 23313491
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel covalent non-β-lactam inhibitor of the metallo-β-lactamase NDM-1.
Christopeit T; Albert A; Leiros HS
Bioorg Med Chem; 2016 Jul; 24(13):2947-2953. PubMed ID: 27184103
[TBL] [Abstract][Full Text] [Related]
16. A Lysine-Targeted Affinity Label for Serine-β-Lactamase Also Covalently Modifies New Delhi Metallo-β-lactamase-1 (NDM-1).
Thomas PW; Cammarata M; Brodbelt JS; Monzingo AF; Pratt RF; Fast W
Biochemistry; 2019 Jun; 58(25):2834-2843. PubMed ID: 31145588
[TBL] [Abstract][Full Text] [Related]
17. Discovery of the Novel Inhibitor Against New Delhi Metallo-β-Lactamase Based on Virtual Screening and Molecular Modelling.
Wang X; Yang Y; Gao Y; Niu X
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443639
[TBL] [Abstract][Full Text] [Related]
18. Mutations in passive residues modulate 3D-structure of NDM (New Delhi metallo-β-lactamase) protein that endue in drug resistance: a MD simulation approach.
Kumar R
J Biomol Struct Dyn; 2022; 40(19):9492-9508. PubMed ID: 34034624
[TBL] [Abstract][Full Text] [Related]
19. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
Khan AU; Ali A; Danishuddin ; Srivastava G; Sharma A
Sci Rep; 2017 Aug; 7(1):9207. PubMed ID: 28835636
[TBL] [Abstract][Full Text] [Related]
20. Boronic Acids as Prospective Inhibitors of Metallo-β-Lactamases: Efficient Chemical Reaction in the Enzymatic Active Site Revealed by Molecular Modeling.
Krivitskaya AV; Khrenova MG
Molecules; 2021 Apr; 26(7):. PubMed ID: 33918209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
